MedTrace Logo

Collaborative Care for Depression and Diabetic Retinopathy in African Americans

NCT02121340 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-02-21

No results posted yet for this study

Summary

In this feasibility/pilot study, we will develop, refine, and evaluate the feasibility of a novel mental health/ophthalmologic intervention called, "Collaborative Care for Depression and Diabetic Retinopathy" (CC-DDR), which aims to treat depression and lower HbA1C in older African Americans with mild-to-moderate diabetic retinopathy (DR) and comorbid depression.

Conditions

Interventions

BEHAVIORAL

Behavioral Activation

Sponsors & Collaborators

  • Wills Eye

    collaborator OTHER

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Barry Rovner, MD · Thomas Jefferson University

  • Robin Casten, PhD · Thomas Jefferson University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02121340 on ClinicalTrials.gov